Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 23
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Ziauddeen, Hisham and Murray, Graham K 2010. The relevance of reward pathways for schizophrenia. Current Opinion in Psychiatry, Vol. 23, Issue. 2, p. 91.

    Murray, G.K. and Fletcher, P.C. 2009. Handbook of Reward and Decision Making.

    Jensen, Jimmy Willeit, Matthäus Zipursky, Robert B Savina, Ioulia Smith, Andrew J Menon, Mahesh Crawley, Adrian P and Kapur, Shitij 2008. The Formation of Abnormal Associations in Schizophrenia: Neural and Behavioral Evidence. Neuropsychopharmacology, Vol. 33, Issue. 3, p. 473.

    Maldonado, José R. 2008. Pathoetiological Model of Delirium: a Comprehensive Understanding of the Neurobiology of Delirium and an Evidence-Based Approach to Prevention and Treatment. Critical Care Clinics, Vol. 24, Issue. 4, p. 789.

    Oades, Robert D. Klimke, Ansgard Henning, Uwe and Rao, Marie Luise 2002. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia. Human Psychopharmacology: Clinical and Experimental, Vol. 17, Issue. 1, p. 15.

    Kapur, Shitij and Remington, Gary 2001. Dopamine D2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biological Psychiatry, Vol. 50, Issue. 11, p. 873.

    Packard, Russell C. 2001. DELIRIUM. The Neurologist, Vol. 7, Issue. 6, p. 327.

    JOSSELYN, S.A. MILLER, R. and BENINGER, R.J. 1997. Behavioral Effects of Clozapine and Dopamine Receptor Subtypes. Neuroscience & Biobehavioral Reviews, Vol. 21, Issue. 5, p. 531.

    Miller, Robert 1997. Dose-response relationships for the antipsychotic effects and Parkinsonian side-effects of typical neuroleptic drugs: Practical and theoretical implications. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 21, Issue. 7, p. 1059.

    Miller, Robert 1993.

    Miller, Robert and Chouinard, Guy 1993. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia. Biological Psychiatry, Vol. 34, Issue. 10, p. 713.

    Goren, Anat Swindell, Carol and Khan, Arifulla 1992. Expressive language characteristics of schizophrenic subjects with different medication histories. Journal of Neurolinguistics, Vol. 7, Issue. 1-2, p. 67.

    Kulkarni, Jayashri Horne, Malcolm Butler, Ernest Keks, Nicholas and Copolov, David 1992. Psychotic symptoms resulting from intraventricular infusion of dopamine in Parkinson's disease. Biological Psychiatry, Vol. 31, Issue. 12, p. 1225.

    1992. Psychology in Medicine.

    Feldon, Joram Shofel, Anat and Weiner, Ina 1991. Latent inhibition is unaffected by direct dopamine agonists. Pharmacology Biochemistry and Behavior, Vol. 38, Issue. 2, p. 309.

    Healy, David 1990. Schizophrenia: Basic, release, reactive and defect processes. Human Psychopharmacology: Clinical and Experimental, Vol. 5, Issue. 2, p. 105.

    Miller, R. Wickens, J.R. and Beninger, R.J. 1990. Dopamine D-1 and D-2 receptors in relation to reward and performance: A case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs. Progress in Neurobiology, Vol. 34, Issue. 2, p. 143.

    Miller, R. 1989. Schizophrenia as a progressive disorder: Relations to EEG, CT. neuropathological and other evidence. Progress in Neurobiology, Vol. 33, Issue. 1, p. 17.

    Miller, Robert 1989. Hyperactivity of Associations in Psychosis. Australian and New Zealand Journal of Psychiatry, Vol. 23, Issue. 2, p. 241.

    Oades, R.D. Rivet, J.-M. Taghzouti, K. Kharouby, M. Simon, H. and Le Moal, M. 1987. Catecholamines and conditioned blocking: effects of ventral tegmental, septal and frontal 6-hydroxydopamine lesions in rats. Brain Research, Vol. 406, Issue. 1-2, p. 136.


Major psychosis and dopamine: controversial features and some suggestions

  • Robert Miller (a1)
  • DOI:
  • Published online: 01 July 2009

Three problems with the dopamine hypothesis of major psychosis are pointed out: the long time-course of neuroleptic therapy; the absence of tolerance to the antipsychotic effects of neuroleptic drugs, or of a supersensitivity psychosis on drug withdrawal; and the absence of potent psychotogenic properties in the direct dopamine agonists. A resolution of these paradoxes is suggested relying on a role for dopamine in learning processes at a relatively high (cognitive) functional level. The hypothesis proposed is also used to explain the origin of some of the more distinctive psychotic symptoms.

Corresponding author
1Address for correspondence: Dr Robert Miller, Department of Anatomy., University of Otago, P.O. Box 913, Dunedin, New Zealand.
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

B. Angrist , H. Thompson , B. Shopsin & S. Gershon (1975). Clinical studies with dopamine-receptor stimulants. Psychopharmacology 44, 273280.

H. Asper , M. Baggiolini , H. R. Burki , H. Lauener , W. Ruch & G. Stille (1973). Tolerance phenomena with neuroleptics. Catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. European Journal of Pharmacology 22, 287294.

N. G. Bacopoulos (1981). Biochemical mechanism of tolerance to neuroleptic drugs: regional differences in rat brain. European Journal of Pharmacology 70, 585586.

N. G. Bacopoulos , G. Bustos , D. E. Redmond , J. Baulu & R. H. Roth (1978). Regional sensitivity of primate brain dopaminergic neurones to halperidol: alterations following chronic treatment. Brain Research 157, 396401.

N. G. Bacopoulos , E. G. Spokes , E. D. Bird & R. H. Roth (1979). Anti-psychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment. Science 205, 14051407.

V. Bannerjee (1971). Acquisition of conditioned avoidance response in rats under the influence of addicting drugs. Psychopharmacologia 22, 133143.

R. J. Beninger (1983). The role of dopamine in locomotor activity and learning. Brain Research Reviews 6, 173196.

R. J. Beninger , & B. L. Hahn (1983). Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science 220, 13041306.

R. J. Beninger , A. G. Phillips & H. C. Fibiger (1983). Prior training and intermittent retraining attenuate pimozide-induced avoidance deficits. Pharmacology, Biochemistry and Behaviour 18, 619624.

C. L. C. Broekkamp & J. M. Van Rossum (1974). Effects of apomorphine on self-stimulation behaviour. Psychopharmacologia 34, 7180.

A. Carlsson & M. Lindqvist (1963). Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacologica et Toxicologica 20, 140144.

J. F. Casey , I. F. Bennett , C. J. Lindley , L. E. Hollister , M. H. Gordon & N. N. Springer (1960). Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital and placebo. Archives of General Psychiatry 2, 210220.

A. Clow , P. Jenner & C. D. Marsden (1979). Changes in dopamine-mediated behaviour during one year's neuroleptic administration. European Journal of Pharmacology 57, 365375.

B. R. Cooper , J. M. Cott & G. R. Breese (1974). Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments. Psychopharmacologia 37, 235248.

H. Corrodi , K. Fuxe , T. Hokfelt , P. Lidbrink & U. Ungerstedt (1973). Effect of ergot drugs on central catecholamine neurones: evidence for a stimulation of central dopamine neurones. Journal of Pharmacy and Pharmacology 25, 409411.

B. Costall & R. J. Naylor (1973). The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat. Naunyn-Schmiedebergs Archiv für experimentalle Pathologie und Pharmakologie 278, 117133.

B. Costall & R. J. Naylor (1975). Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine. Psychopharmacologia 43, 6975.

T. J. Crow , P. J. Spear & G. W. Arbuthnott (1972). lntracranial self-stimulation with electrodes in the region of the locus coeruleus. Brain Research 36, 275287.

T. J. Crow , H. F. Baker , A. J. Cross , M. H. Joseph , R. Lofthouse , A. Longden , F. Owen , G. J. Riley , V. Glover & W. S. Killpach (1979). Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings. British Journal of Psychiatry 134, 249256.

A. B. Davidson & E. Weidley (1976). Differential effects of neuroleptic and other psychotic agents on acquisition of avoidance in rats. Life Sciences 18, 12791284.

J. A. Davies , B. Jackson & P. H. Redfern (1974). The effect of amantadine, L-DOPA, (+) amphetamine and apomorphine on the acquisition of the conditioned avoidance response. Neuropharmacology 13, 199204.

P. Deniker (1960). Experimental neurological syndromes and the new drug therapies in psychiatry. Comprehensive Psychiatry 1, 92102.

R. C. Duvoisin , R. E. Heikkila & L. Manzino (1982). Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway. Neurology 32, 13781391.

H. C. Fibiger , H. P. Fibiger & A. P. Zis (1973). Attentuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat. British Journal of Pharmacology 47, 683692.

K. A. Freedberg , R. B. Innis , I. Creese & S. H. Snyder (1979). Anti-schizophrenic drugs: differential plasma protein binding and therapeutic activity. Life Sciences 24, 24672474.

T. G. Heffner , D. Luttinger , J. A. Hartman & L. S. Seiden (1981). Regional changes in brain catecholamine turnover in the rat during performance on fixed ratio and variable interval schedules of reinforcement. Brain Research 214, 215219.

O. Hornykiewicz (1982). Brain catecholamines in schizophrenia–a good case for noradrenaline. Nature (London) 299, 484486.

G. Johnson , S. Gershon , E. I. Burdock , A. Floyd & L. Hekiman (1971). Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. British Journal of Psychiatry 119, 267276.

P. Laduron , K. De Bie & J. Leysen (1977). Specific effect of haloperidol on dopamine turnover in the frontal cortex. Naunyn-Schmiedebergs Archiv für experimentalle Pathologie und Pharmakologie 296, 183185.

H. E. Lehmann & G. E. Hanrahan (1954). Chlorpromazine. New inhibiting agent for psychomotor excitement and manic states. Archives of Neurology and Psychiatry 71, 227237.

M. Le Moal , L. Stinus & D. Galey (1976). Radio frequency lesions of the ventral mesencephalic tegmentum: neurological and behavioural considerations. Experimental Neurology 50, 521525.

J. E. Leysen , C. J. Niemegeers , J. P. Tollenaere & P. M. Laduron (1978). Serotonergic component of neuroleptic receptors. Nature (London) 272, 168171.

A. V. P. Mackay , L. L. Iversen , M. Rossor , E. Spokes , E. Bird , A. Arregui , I. Creese & S. H. Snyder (1982). Increased brain dopamine and dopamine receptors in schizophrenia. Archives of General Psychiatry 39, 991997.

T. Matsumoto , H. Uchimura , M. Hirano , J. Soo Kim , H. Yokoo , M. Shimomura , T. Nakahara , K. Inoue & K. Oomagari (1983). Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete areas of rat brain. European Journal of Pharmacology 89, 2733.

F. Mora , A. G. Phillips , J. M. Koolhaas & E. T. Rolls (1976). Prefrontal cortex and neostriatum self-stimulation in the rat: differential effects produced by apomorphine. Brain Research Bulletin 1, 421424.

H. R. Olpe & W. P. Koella (1979). Inhibition of nigral and neocortical cells by γ-hydroxybutyrate: a microiontophroetic investigation. European Journal of Pharmacology 53, 359364.

R. F. Prien , E. M. Caffey & J. C. Klett (1972). Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Archives of General Psychiatry 26, 146153.

A. Randrup , I. Munkvad & P. Udsen (1963). Adrenergic mechanisms and amphetamine-induced abnormal behaviour. Acta Pharmacologica et Toxicologia 20, 145157.

B. Rensch & H. Rahmann (1960). Einfluss des Pervitins auf das Gedachtnis von Goldhamstern. Pflügers Archivs für die gesamte Physiologie 271, 693704.

G. P. Reynolds (1983). Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature (London) 305, 527529.

R. H. Roth , J. D. Doherty & J. R. Walters (1980). Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons? Brain Research 189, 556560.

B. Scatton (1977). Differential regional development of the tolerance to increase in dopamine turnover upon repeated neuroleptic administration. European Journal of Pharmacology 46, 363369.

S. Ch. Schultz , D. P. Van Kammen , M. S. Buchsbaum , R. H. Roth , P. Alexander & W. E. Bunney (1981). Gamma-hydroxy-butyrate treatment of schizophrenia: a pilot study. Pharmaco-psychiatria 14, 129134.

P. A. Shore (1976). Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. Journal of Pharmacy and Pharmacology 28, 855857.

H. Simon , B. Scatton & Moal M. Le (1980). Dopaminergic A10 neurones are involved in cognitive functions. Nature 286, 150151.

J. St Laurent , R. R. Le Clerc , M. L. Mitchell & T. E. Miliaressis (1973). Effects of apomorphine on self-stimulation. Pharmacology Biochemistry and Biochemistry and Behaviour 1, 581585.

D. Tarsy & R. J. Baldessarini (1974). Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology 13, 927940.

J. P. Tassin , L. Stinus , H. Simon , G. Blanc , A. M. Thierry , M. Le Moal , B. Cardo & J. Glowinski (1978). Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Research 141, 267281.

J. E. Thornberg & K. E. Moore (1974). A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice. Neuropharmacology 13, 189197.

H. N. Wagner Jr, D. H. Burns , R. F. Dannals , D. F. Wong , B. Langstrom , T. Duelfer , J. J. Frost , H. T. Ravert , J. M. Links , S. B. Rosenbloom , S. E. Lukas , A. V. Kramer & M. J. Kuhar (1983). Imaging dopamine receptors in the human brain by positron tomography. Science 221, 12641266.

A. Wauquier & C. J. E. Niemegeers (1973). Intracranial self-stimulation in rats as a function of various stimulus parameters. III. Influence of apomorphine on medial forebrain bundle stimulation with monopolar electrodes. Psychopharmacologia 30, 163172.

F. J. White & R. Y. Wang (1983). Differential effects of classical and atypical anti-psychotic drugs on A9 and A10 dopamine neurons. Science 221, 10541057.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *